Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 2:58 AM
Study NCT ID:
NCT05610202
Status:
UNKNOWN
Last Update Posted:
2022-11-09
First Post:
2022-11-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-02
First Submit QC Date:
None
Study First Post Date:
2022-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-02
Last Update Post Date:
2022-11-09
Last Update Post Date Type:
ACTUAL